Antibiotic use and Influencing Factors Among Hospitalized Patients with COVID-19: A Multicenter Point-Prevalence Study from Turkey
dc.authorid | Karabay, Oguz/0000-0003-1514-1685 | |
dc.authorid | demirbaş, zehra/0000-0002-5814-5398 | |
dc.authorid | EREN KUTSOYLU, oya/0000-0003-3814-0474 | |
dc.authorid | Sayar, Merve Sefa/0000-0002-0436-4122 | |
dc.authorid | Kuzi, Semanur/0000-0001-6496-1773 | |
dc.authorid | Unver Ulusoy, Tulay/0000-0002-0172-2326 | |
dc.authorid | Cag, Yasemin/0000-0002-9983-0308 | |
dc.authorscopusid | 57200000454 | |
dc.authorscopusid | 35764273000 | |
dc.authorscopusid | 23060531400 | |
dc.authorscopusid | 25225546400 | |
dc.authorscopusid | 23008184300 | |
dc.authorscopusid | 36158552200 | |
dc.authorscopusid | 57219203549 | |
dc.authorwosid | Karabay, Oguz/HHN-5893-2022 | |
dc.authorwosid | Cag, Yasemin/S-7343-2016 | |
dc.authorwosid | Bektaş, Begüm/GQB-4719-2022 | |
dc.authorwosid | demirbaş, zehra/GPK-7612-2022 | |
dc.authorwosid | EREN KUTSOYLU, oya/Y-9180-2018 | |
dc.authorwosid | Sayar, Merve Sefa/GVS-7640-2022 | |
dc.authorwosid | kul, gülnur/GQY-4432-2022 | |
dc.contributor.author | Sencan, Irfan | |
dc.contributor.author | Cag, Yasemin | |
dc.contributor.author | Karabay, Oguz | |
dc.contributor.author | Kurtaran, Behice | |
dc.contributor.author | Guclu, Ertugrul | |
dc.contributor.author | Ogutlu, Aziz | |
dc.contributor.author | Demirbas, Zehra | |
dc.date.accessioned | 2023-01-12T20:16:30Z | |
dc.date.available | 2023-01-12T20:16:30Z | |
dc.date.issued | 2022 | |
dc.department | N/A/Department | en_US |
dc.description.abstract | Background: Broad-spectrum empirical antimicrobials arc frequently prescribed for patients with coronavirus disease 2019 (COVID-19) despite the lack of evidence for bacterial coinfection. Aims: We aimed to cross-sectionally determine the frequency of antibiotics use, type of antibiotics prescribed, and the factors influencing antibiotics use in hospitalized patients with COVID-19 confirmed by polymerase chain reaction. Study Design: The study was a national, multicenter, retrospective. and single-day point prevalence study. Methods: This was a national, multicenter, retrospective, and single-day point-prevalence study, conducted in the 24-h period between 00:00 and 24:00 on November 18, 2020, during the start of the second COVID-19 peak in Turkey. Results: A total of 1500 patients hospitalized with a diagnosis of COVID-19 were included in the study. The mean age +/- standard deviation of the patients was 65.0 +/- 15.5, and 56.2% (n = 843) of these patients were men. Of these hospitalized patients, 11.9% (n = 178) were undergoing invasive mechanical ventilation or ECMO. It was observed that 1118 (74.5%) patients were receiving antibiotics, of which 416 (372%) were prescribed a combination of antibiotics. In total, 71.2% of the patients had neither a clinical diagnosis nor microbiological evidence for prescribing antibiotics. In the multivariate logistic regression analysis, hospitalization in a state hospital (p < 0.001), requiring any supplemental oxygen (p = 0.005). presence of moderate/diffuse lung involvement (p < 0.001), C-reactive protein >10 ULT coefficient (p < 0.001), lymphocyte count < 800 (p = 0.007), and clinical diagnosis and/or confirmation by culture (p <0.001) were found to be independent factors associated with increased antibiotic use. Conclusion: The necessity of empirical antibiotics use in patients with COVID-19 should be reconsidered according to their clinical, imaging, and laboratory findings. | en_US |
dc.identifier.doi | 10.4274/balkanmedj.galenos.2022.2021-11-62 | |
dc.identifier.endpage | 217 | en_US |
dc.identifier.issn | 2146-3123 | |
dc.identifier.issn | 2146-3131 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 35611705 | en_US |
dc.identifier.scopus | 2-s2.0-85133362344 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 209 | en_US |
dc.identifier.uri | https://doi.org/10.4274/balkanmedj.galenos.2022.2021-11-62 | |
dc.identifier.uri | https://hdl.handle.net/11454/78725 | |
dc.identifier.volume | 39 | en_US |
dc.identifier.wos | WOS:000806079300007 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Galenos Publ House | en_US |
dc.relation.ispartof | Balkan Medical Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Bacterial Coinfection | en_US |
dc.subject | Stewardship | en_US |
dc.title | Antibiotic use and Influencing Factors Among Hospitalized Patients with COVID-19: A Multicenter Point-Prevalence Study from Turkey | en_US |
dc.type | Article | en_US |